NCT03082222View on ClinicalTrials.gov

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

CompletedOBSERVATIONAL

Enrollment

246

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 29, 2018

Study Completion Date

October 29, 2018

Conditions

Focal Epilepsy

Trial Locations (1)

Unknown

Multiple Locations

All Listed Sponsors

lead

Eisai GmbH

INDUSTRY

NCT03082222 - ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions | Biotech Hunter | Biotech Hunter